Hosted on MSN18d
MediWound announces Phase III CIDS publication on NexoBridThese results reinforce NexoBrid’s clinical benefits as a rapid, effective, and non-surgical alternative for eschar removal in pediatric burn patients, validating its significance as a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results